Anti-MRAP2/ C6orf117/ bA51G5.2 monoclonal antibody

Anti-MRAP2/ C6orf117/ bA51G5.2 antibody for FACS & in-vivo assay

Target products collectionGo to MRAP2/MRAP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0829-Ab-1/ GM-Tg-hg-MP0829-Ab-2Anti-Human MRAP2 monoclonal antibodyHuman
GM-Tg-rg-MP0829-Ab-1/ GM-Tg-rg-MP0829-Ab-2Anti-Rat MRAP2 monoclonal antibodyRat
GM-Tg-mg-MP0829-Ab-1/ GM-Tg-mg-MP0829-Ab-2Anti-Mouse MRAP2 monoclonal antibodyMouse
GM-Tg-cynog-MP0829-Ab-1/ GM-Tg-cynog-MP0829-Ab-2Anti-Cynomolgus/ Rhesus macaque MRAP2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0829-Ab-1/ GM-Tg-felg-MP0829-Ab-2Anti-Feline MRAP2 monoclonal antibodyFeline
GM-Tg-cang-MP0829-Ab-1/ GM-Tg-cang-MP0829-Ab-2Anti-Canine MRAP2 monoclonal antibodyCanine
GM-Tg-bovg-MP0829-Ab-1/ GM-Tg-bovg-MP0829-Ab-2Anti-Bovine MRAP2 monoclonal antibodyBovine
GM-Tg-equg-MP0829-Ab-1/ GM-Tg-equg-MP0829-Ab-2Anti-Equine MRAP2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0829-Ab-1/ GM-Tg-hg-MP0829-Ab-2; GM-Tg-rg-MP0829-Ab-1/ GM-Tg-rg-MP0829-Ab-2;
GM-Tg-mg-MP0829-Ab-1/ GM-Tg-mg-MP0829-Ab-2; GM-Tg-cynog-MP0829-Ab-1/ GM-Tg-cynog-MP0829-Ab-2;
GM-Tg-felg-MP0829-Ab-1/ GM-Tg-felg-MP0829-Ab-2; GM-Tg-cang-MP0829-Ab-1/ GM-Tg-cang-MP0829-Ab-2;
GM-Tg-bovg-MP0829-Ab-1/ GM-Tg-bovg-MP0829-Ab-2; GM-Tg-equg-MP0829-Ab-1/ GM-Tg-equg-MP0829-Ab-2
Products NameAnti-MRAP2 monoclonal antibody
Formatmab
Target NameMRAP2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-MRAP2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species MRAP2/ C6orf117/ bA51G5.2 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP004128human MRAP2 Lentivirus plasmid
    ORF Viral VectorvGMLP004128human MRAP2 Lentivirus particle
    ORF Viral VectorpGMLPm003303mouse Mrap2 Lentivirus plasmid
    ORF Viral VectorvGMLPm003303mouse Mrap2 Lentivirus particle


    Target information

    Target IDGM-MP0829
    Target NameMRAP2
    Gene ID112609,244958,363112,611524,101083426,781188,100065482
    Gene Symbol and SynonymsbA51G5.2,C6orf117,C9H6ORF117,MRAP2,RGD1309873
    Uniprot AccessionQ96G30
    Uniprot Entry NameMRAP2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000135324
    Target ClassificationN/A

    The target: MRAP2, gene name: MRAP2, also named as C6orf117, bA51G5.2. This gene encodes a protein that modulates melanocortin receptor signaling. The encoded protein has been shown to interact with all known melanocortin receptors and may regulate both receptor trafficking and activation in response to ligands. Mice lacking a functional copy of this gene exhibit severe obesity and a mutation in this gene may be associated with severe obesity in human patients. [provided by RefSeq, Oct 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.